166 related articles for article (PubMed ID: 9531598)
1. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis.
Plumas J; Jacob MC; Chaperot L; Molens JP; Sotto JJ; Bensa JC
Blood; 1998 Apr; 91(8):2875-85. PubMed ID: 9531598
[TBL] [Abstract][Full Text] [Related]
2. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.
Schattner EJ; Friedman SM; Casali P
Autoimmunity; 2002 Jul; 35(4):283-9. PubMed ID: 12482198
[TBL] [Abstract][Full Text] [Related]
6. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.
Xerri L; Bouabdallah R; Devilard E; Hassoun J; Stoppa AM; Birg F
Br J Cancer; 1998 Jul; 78(2):225-32. PubMed ID: 9683298
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to HLA class I alpha1 domain trigger apoptosis of CD40-activated human B lymphocytes.
Genestier L; Meffre G; Garrone P; Pin JJ; Liu YJ; Banchereau J; Revillard JP
Blood; 1997 Jul; 90(2):726-35. PubMed ID: 9226173
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
10. Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin.
Benoit NE; Wade WF
Immunopharmacology; 1996 Nov; 35(2):129-39. PubMed ID: 8956976
[TBL] [Abstract][Full Text] [Related]
11. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K.
Benson RJ; Hostager BS; Bishop GA
Eur J Immunol; 2006 Sep; 36(9):2535-43. PubMed ID: 16897814
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
[TBL] [Abstract][Full Text] [Related]
13. High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants.
De Paoli P; Cozzi M; Tedeschi R; Gloghini A; Cilia AM; van Kooten C; Gaidano G; Carbone A
Cytometry; 1997 Feb; 30(1):33-8. PubMed ID: 9056740
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
[TBL] [Abstract][Full Text] [Related]
15. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.
Komada Y; Zhou YW; Zhang XL; Chen TX; Tanaka S; Azuma E; Sakurai M
Br J Haematol; 1997 Jan; 96(1):147-57. PubMed ID: 9012700
[TBL] [Abstract][Full Text] [Related]
16. IL-7 sensitizes human pre-B cells but not pro-B cells to Fas/APO-1 (CD95)-mediated apoptosis.
Levy Y; Benlagha K; Buzyn A; Colombel M; Brouet JC; Lassoued K
Clin Exp Immunol; 1997 Nov; 110(2):329-35. PubMed ID: 9367421
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity.
Costello RT; Mallet F; Barbarat B; Schiano De Colella JM; Sainty D; Sweet RW; Truneh A; Olive D
Leukemia; 2003 Dec; 17(12):2500-7. PubMed ID: 14562115
[TBL] [Abstract][Full Text] [Related]
18. Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line.
Irisarri M; Plumas J; Bonnefoix T; Jacob MC; Roucard C; Pasquier MA; Sotto JJ; Lajmanovich A
Leukemia; 2000 Dec; 14(12):2149-58. PubMed ID: 11187905
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
[TBL] [Abstract][Full Text] [Related]
20. Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells.
Lajmanovich A; Irisarri M; Molens JP; Pasquier MA; Sotto JJ; Bensa JC; Leroux D; Plumas J
Br J Haematol; 2004 Mar; 124(6):746-53. PubMed ID: 15009062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
